Aug. 19, 2020 — A broadly utilised coronavirus examination could make inaccurate final results thanks to issues with the devices and software program utilised to run the examination, the U.S. Foodstuff and Drug Administration warned Monday.

The company issued the inform about Thermo Fisher’s TaqPath genetic examination, the Related Push noted.

The business is functioning with the Food and drug administration “to make absolutely sure that laboratory staff realize the need to have for stringent adherence to the instructions for use,” in accordance to a spokeswoman for Thermo Fisher.

The Food and drug administration did not reveal how a lot of inaccurate examination final results there have been, the AP noted.

WebMD Information from HealthDay

Copyright © 2013-2020 HealthDay. All rights reserved.